FDA Drug Recalls

Recalls / Class II

Class IID-0695-2018

Product

Ibuprofen Caplets USP 200 mg, a) 50 caplets (NDC 53943-292-15), b) 100 caplets (NDC 53493-292-12), and c) 500 caplets (NDC 53493-292-14) bottles, Distributed by Drug Mart, Food Fair, Medina, Ohio 44256, Manufactured by: Marksans Pharma, Ltd., Verna, Goa-403 722, India

Brand name
Ibuprofen
Generic name
Ibuprofen
Active ingredient
Ibuprofen
Route
Oral
NDC
53943-292
FDA application
ANDA075010
Affected lot / code info
a) F066C b) F066C c) F066C

Why it was recalled

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Recalling firm

Firm
Time-Cap Laboratories, Inc.
Manufacturer
Discount Drug Mart
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7 Michael Ave, N/A, Farmingdale, New York 11735-3921

Distribution

Quantity
N/A
Distribution pattern
Nationwide.

Timeline

Recall initiated
2018-01-11
FDA classified
2018-04-22
Posted by FDA
2018-05-02
Terminated
2021-01-20
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0695-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.